GL1X · GenesisL1 explorer

Research workbench

Crystal structure of zaire ebola VP35 interferon inhibitory domain K319A/R322A mutant

Analyse Crystal structure of zaire ebola VP35 interferon inhibitory domain K319A/R322A… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3L29
Type
protein
Length
250 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Polymerase cofactor VP35
UniProt
Q05127
Ligands
CL
Pockets
1 · best druggability 0.70

Structure

x-ray diffraction · 2 distinct chains · 52% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APolymerase cofactor VP35protein12354% helix, 15% strandQ05127
BPolymerase cofactor VP35protein12751% helix, 13% strandQ05127

Ligands and binding sites

  • CL · Chloride ion · ion · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17780.700.7656empty

Interfaces

1 interface between chains.

  • A–B · 249 Ų buried · 1 hydrogen bond · protein-protein

Compared structures

  • 3L29 · Crystal Structure of Zaire Ebola VP35 interferon inhibitory domain K319A/R322A mutant · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.